Building Effective Policy Solutions

Securing stable access to medicine for current and future patients in Europe and around the world can only be achieved through policy dialogue and collaboration. We are committed to being a partner in search of solutions that ensure the sustainability of our healthcare system.

Policy for Access

Healthy Off-Patent Medicine Market

Off-patent medicines account for 70% of medicines taken by European patients and are drivers of equitable access. Spikes in production and supply costs are challenging continued availability of many off-patent medicines. Urgent action is needed to secure access.

VAM: Improving Patient Outcomes with Existing Medicines

Value Added Medicines have the potential to improve health outcomes and reduce health system costs, but steps must be taken to enable their development and use.

Green Deal

Environmental Stewardship

We are committed to working with EU institutions and partners along the medicines value chain to address potential environmental concerns while responding to patient needs and ensuring access to medicines.